Invention Grant
- Patent Title: Multi-CBV vaccine for preventing or treating type I diabetes
-
Application No.: US16265677Application Date: 2019-02-01
-
Publication No.: US10675344B2Publication Date: 2020-06-09
- Inventor: Hyöty Heikki , Mikael Knip , Olli Laitinen , Outi Tolonen , Minna Pulkki , Sami Oikarinen , Hanna-Riikka Honkanen , Valérie Lecouturier , Jeffrey Almond , Malin Flodström-Tullberg
- Applicant: Vactech Oy
- Applicant Address: FI Tampere
- Assignee: Vactech 0y
- Current Assignee: Vactech 0y
- Current Assignee Address: FI Tampere
- Agency: Bozicevic Field & Francis, LLP
- Agent Paula A. Borden
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@2dadeef4
- Main IPC: A61K39/125
- IPC: A61K39/125 ; A61K39/12 ; C07K16/10 ; A61K39/13 ; A61K39/39 ; A61K39/00
Abstract:
The invention is directed to a vaccine comprising: i) coxsackie B virus CBV1 and CBV2, and ii) at least one coxsackie B virus selected from CBV3, CBV4, CBV5 and CBV6. The CBVs are present in the vaccine in inactivated form, in the form of a component of the virus or as an antibody against the virus. The vaccine is effective in preventing and treating type 1 diabetes. So is an anti-coxsackie B virus composition provided.
Public/Granted literature
- US20190209675A1 MULTI-CBV VACCINE FOR PREVENTING OR TREATING TYPE I DIABETES Public/Granted day:2019-07-11
Information query
